Data / Form D filings / EMERAMED Ltd
EMERAMED Ltd: Form D filings
EMERAMED Ltd, a pharmaceuticals company in Dublin, Ireland, filed 6 Form D notices with the SEC between 2014 and 2018. The latest, on February 12, 2018, reports an offering of no set size with nothing sold yet.
Find out what EMERAMED Ltd does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- TRINITY HOUSE, CHARLESTON ROAD, RANELAGH, Dublin, Ireland, 6
- Phone
- (859) 266-9200
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Ireland
- Year incorporated
- 2014
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1623416
The full lists. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 12, 2018 | New notice | Indefinite | $0 | Indefinite | 0 | Yet to occur | sec.gov |
| Nov 15, 2016 | New notice | Indefinite | $274,217 | Indefinite | 6 | Nov 2, 2016 | sec.gov |
| Jun 17, 2016 | Amendment | Indefinite | $3,585,788 | Indefinite | 57 | Nov 10, 2014 | sec.gov |
| Feb 29, 2016 | New notice | Indefinite | $2,773,940 | Indefinite | 32 | Nov 10, 2014 | sec.gov |
| Oct 20, 2015 | Amendment | $2,574,000 | $2,044,545 | $529,455 | 26 | Nov 10, 2014 | sec.gov |
| Oct 30, 2014 | New notice | $1,514,160 | $0 | $1,514,160 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| BOYD E HALEY | Executive Officer, Director | |
| DAVID C KENNEDY | Director | |
| RAGNAR E KLINGBERG | Executive Officer, Director | |
| KATHRYN M WACHSMAN | Director |
Every Form D from the week of Feb 12, 2018 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what EMERAMED Ltd reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.